SELLAS Life Sciences (SLS) Change in Inventory (2013 - 2015)
SELLAS Life Sciences (SLS) reported Change in Inventory of $789000.0 for Q2 2015, up 952.0% year-over-year from $75000.0 in Q2 2014, and up 4483.33% on a QoQ basis from -$18000.0 in Q1 2015.
SELLAS Life Sciences (SLS) has 3 years of Change in Inventory data on file, last reported at $789000.0 in Q2 2015.
- Quarterly Change in Inventory rose 952.0% year-over-year to $789000.0 in Q2 2015, while the trailing twelve-month figure through Jun 2015 was $993000.0 (up 1125.93% YoY) and the FY2014 annual result came in at $269000.0, down 30.31% from the prior year.
- Change in Inventory rose to $789000.0 in Q2 2015 per SLS's latest filing, from -$18000.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $789000.0 in Q2 2015 and bottomed at -$39000.0 in Q4 2013.
- The 3-year median for Change in Inventory is $73000.0 (2013), against an average of $158444.4.
- The widest annual swing landed in 2014, when Change in Inventory slumped 78.69%; it then jumped 952.0% in 2015.
- Tracing SLS's Change in Inventory over 3 years: stood at -$39000.0 in 2013, then surged by 625.64% to $205000.0 in 2014, then jumped by 284.88% to $789000.0 in 2015.
- Per Business Quant, the three latest SLS Change in Inventory figures stand at $789000.0 (Q2 2015), -$18000.0 (Q1 2015), and $205000.0 (Q4 2014).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 665.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 97.70 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -26.60 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 3.32 Mn |
| 10 | SELLAS Life Sciences | 1.61 Bn | 1.61 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 789,000.00 |
| Jun 30, 2015 | 789,000.00 |
| Mar 31, 2015 | -18,000.00 |
| Mar 31, 2015 | -18,000.00 |
| Dec 31, 2014 | 205,000.00 |
| Dec 31, 2014 | 205,000.00 |
| Sep 30, 2014 | 17,000.00 |
| Sep 30, 2014 | 17,000.00 |
| Jun 30, 2014 | 75,000.00 |
| Jun 30, 2014 | 75,000.00 |
| Mar 31, 2014 | -28,000.00 |
| Mar 31, 2014 | -28,000.00 |
| Dec 31, 2013 | -39,000.00 |
| Dec 31, 2013 | -39,000.00 |
| Sep 30, 2013 | 73,000.00 |
| Sep 30, 2013 | 73,000.00 |
| Jun 30, 2013 | 352,000.00 |
| Jun 30, 2013 | 352,000.00 |